SomnoMed North America

This week marks a significant milestone for us at SomnoMed as we welcome Amrita Blickstead and Karen Borg as our newly appointed co-CEOs. Their leadership will steer us into the next chapter of growth and innovation. As we embark on this journey, our goal is to share not just our vision and mission, but also the essence of who we are and what drives us. We invite you to read the attached release to understand the direction we're heading and our continued commitment to Treat More OSA Patients, More Effectively. Your trust and partnership mean the world to us, and we look forward to continuing this journey together. #MedicalInitiative #Leadership #Growth #Innovation #Healthcare

Benjamin’s journey with Obstructive Sleep Apnea (OSA) began when his wife noticed he was not just snoring, but would also stop breathing during the night. A sleep test confirmed his OSA, and he opted for a SomnoMed oral device for effective treatment. Today, Benjamin is more energized, keeps up with his young kids, and - perhaps most importantly - shares a room with his wife again. He’a shared how his sleep quality and overall well-being have dramatically improved. Together, we can make a real difference in the lives of those with OSA: https://bit.ly/4earbTa #SleepApnea #HealthcareInnovation #PatientStory #SomnoMed

We’re thrilled to welcome Scott Jacobson back to the #SomTEAM! 🎉 Scott began his career at Patterson Dental before discovering his passion for dental sleep medicine. His journey in dental sleep began with SomnoMed back in 2014, and he has since gained valuable experience at ProSomnus and Zoll Itamar Medical. Scott’s return elevates our already exceptional team culture as we continue to help patients improve their lives through better #sleep. Outside of work, Scott is busy coaching his three kids’ youth sports teams—a role he absolutely loves! #getSOMsleep #welcome #herewegrowagain #sleepapnea

Our mission is to help treat more OSA patients, more effectively - so we love seeing testimonials like these! To date, we’ve provided sleep apnea treatment to over 915,000 people worldwide. Learn more about our oral devices and our mission: https://bit.ly/4earbTa #sleepapnea #sleepapneatreatment #oralappliancetherapy

Are you or your patients planning a summer getaway with a SomnoMed device? We've got you covered on both portability and hygiene. Our bundle offers ensure all appliances and accessories stay clean and neatly packed during travels. Stock up here: https://bit.ly/getsomtabs #oralappliancetherapy #sleepapnea #travel #snoring

𝐒𝐨𝐦𝐧𝐨𝐃𝐞𝐧𝐭 𝐀𝐯𝐚𝐧𝐭: 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐢𝐧𝐠 𝐚𝐧 𝐀𝐇𝐈 𝐨𝐟 𝟔.𝟏 𝐢𝐧 𝐦𝐨𝐝𝐞𝐫𝐚𝐭𝐞-𝐬𝐞𝐯𝐞𝐫𝐞 𝐎𝐒𝐀¹ Clinical studies commonly report CPAP therapy reducing AHI to 2-8 events/h.ᒾ SomnoDent Avant reduces AHI to 6.1 in moderate-severe OSA. Read the research paper: https://lnkd.in/e7HC6SKG #SomnoMed #SomnnoDentAvant #OSAPatients ¹𝘝𝘢𝘯𝘥𝘦𝘳𝘷𝘦𝘬𝘦𝘯 𝘖𝘔, 𝘝𝘢𝘯 𝘋𝘢𝘦𝘭𝘦 𝘔, 𝘝𝘦𝘳𝘣𝘳𝘢𝘦𝘤𝘬𝘦𝘯 𝘑, 𝘉𝘳𝘢𝘦𝘮 𝘔𝘑, 𝘋𝘪𝘦𝘭𝘵𝘫𝘦𝘯𝘴 𝘔. 𝘊𝘰𝘮𝘱𝘢𝘳𝘢𝘵𝘪𝘷𝘦 𝘢𝘯𝘢𝘭𝘺𝘴𝘪𝘴 𝘰𝘧 𝘵𝘸𝘰 𝘤𝘶𝘴𝘵𝘰𝘮-𝘮𝘢𝘥𝘦 𝘮𝘢𝘯𝘥𝘪𝘣𝘶𝘭𝘢𝘳 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘮𝘦𝘯𝘵 𝘥𝘦𝘷𝘪𝘤𝘦𝘴 𝘸𝘪𝘵𝘩 𝘷𝘢𝘳𝘪𝘦𝘥 𝘥𝘦𝘴𝘪𝘨𝘯𝘴 𝘧𝘰𝘳 𝘵𝘳𝘦𝘢𝘵𝘪𝘯𝘨 𝘮𝘰𝘥𝘦𝘳𝘢𝘵𝘦 𝘵𝘰 𝘴𝘦𝘷𝘦𝘳𝘦 𝘰𝘣𝘴𝘵𝘳𝘶𝘤𝘵𝘪𝘷𝘦 𝘴𝘭𝘦𝘦𝘱 𝘢𝘱𝘯𝘦𝘢. 𝘚𝘭𝘦𝘦𝘱 𝘔𝘦𝘥. 2024 𝘔𝘢𝘺;117:95-98. 𝘥𝘰𝘪: 10.1016/𝘫.𝘴𝘭𝘦𝘦𝘱.2024.02.035. 𝘌𝘱𝘶𝘣 2024 𝘔𝘢𝘳 7. 𝘗𝘔𝘐𝘋: 38518588. ᒾ𝘚𝘶𝘵𝘩𝘦𝘳𝘭𝘢𝘯𝘥, 𝘒𝘢𝘵𝘦 & 𝘗𝘩𝘪𝘭𝘭𝘪𝘱𝘴, 𝘊𝘳𝘢𝘪𝘨 & 𝘊𝘪𝘴𝘵𝘶𝘭𝘭𝘪, 𝘗𝘦𝘵𝘦𝘳. (2015). 𝘌𝘧𝘧𝘪𝘤𝘢𝘤𝘺 𝘷𝘦𝘳𝘴𝘶𝘴 𝘌𝘧𝘧𝘦𝘤𝘵𝘪𝘷𝘦𝘯𝘦𝘴𝘴 𝘪𝘯 𝘵𝘩𝘦 𝘛𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 𝘰𝘧 𝘖𝘣𝘴𝘵𝘳𝘶𝘤𝘵𝘪𝘷𝘦 𝘚𝘭𝘦𝘦𝘱 𝘈𝘱𝘯𝘦𝘢: 𝘊𝘗𝘈𝘗 𝘢𝘯𝘥 𝘖𝘳𝘢𝘭 𝘈𝘱𝘱𝘭𝘪𝘢𝘯𝘤𝘦𝘴. 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘋𝘦𝘯𝘵𝘢𝘭 𝘚𝘭𝘦𝘦𝘱 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦. 02. 175-181. 10.15331/𝘫𝘥𝘴𝘮.5120.

𝐒𝐨𝐦𝐧𝐨𝐃𝐞𝐧𝐭 𝐀𝐯𝐚𝐧𝐭: 𝐆𝐫𝐞𝐚𝐭𝐞𝐫 𝐞𝐟𝐟𝐢𝐜𝐚𝐜𝐲 𝐭𝐡𝐚𝐧 𝐰𝐢𝐧𝐠-𝐛𝐚𝐬𝐞𝐝 𝐝𝐞𝐯𝐢𝐜𝐞𝐬¹ Studies with wing-based devices have typically reported treatment success as AHI <10 and 50% reduction in AHIᒾ. SomnoDent Avant delivers an AHI of 6.1 with 70% AHI reduction in moderate-severe OSA patients. Read the research paper here: https://lnkd.in/e7HC6SKG #SomnoMed #SomnnoDentAvant #OSAPatients ¹𝘝𝘢𝘯𝘥𝘦𝘳𝘷𝘦𝘬𝘦𝘯 𝘖𝘔, 𝘝𝘢𝘯 𝘋𝘢𝘦𝘭𝘦 𝘔, 𝘝𝘦𝘳𝘣𝘳𝘢𝘦𝘤𝘬𝘦𝘯 𝘑, 𝘉𝘳𝘢𝘦𝘮 𝘔𝘑, 𝘋𝘪𝘦𝘭𝘵𝘫𝘦𝘯𝘴 𝘔. 𝘊𝘰𝘮𝘱𝘢𝘳𝘢𝘵𝘪𝘷𝘦 𝘢𝘯𝘢𝘭𝘺𝘴𝘪𝘴 𝘰𝘧 𝘵𝘸𝘰 𝘤𝘶𝘴𝘵𝘰𝘮-𝘮𝘢𝘥𝘦 𝘮𝘢𝘯𝘥𝘪𝘣𝘶𝘭𝘢𝘳 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘮𝘦𝘯𝘵 𝘥𝘦𝘷𝘪𝘤𝘦𝘴 𝘸𝘪𝘵𝘩 𝘷𝘢𝘳𝘪𝘦𝘥 𝘥𝘦𝘴𝘪𝘨𝘯𝘴 𝘧𝘰𝘳 𝘵𝘳𝘦𝘢𝘵𝘪𝘯𝘨 𝘮𝘰𝘥𝘦𝘳𝘢𝘵𝘦 𝘵𝘰 𝘴𝘦𝘷𝘦𝘳𝘦 𝘰𝘣𝘴𝘵𝘳𝘶𝘤𝘵𝘪𝘷𝘦 𝘴𝘭𝘦𝘦𝘱 𝘢𝘱𝘯𝘦𝘢. 𝘚𝘭𝘦𝘦𝘱 𝘔𝘦𝘥. 2024 𝘔𝘢𝘺;117:95-98. 𝘥𝘰𝘪: 10.1016/𝘫.𝘴𝘭𝘦𝘦𝘱.2024.02.035. 𝘌𝘱𝘶𝘣 2024 𝘔𝘢𝘳 7. 𝘗𝘔𝘐𝘋: 38518588. ᒾ𝘚𝘩𝘪, 𝘟., 𝘓𝘰𝘣𝘣𝘦𝘻𝘰𝘰, 𝘍., 𝘊𝘩𝘦𝘯, 𝘏. 𝘦𝘵 𝘢𝘭. 𝘊𝘰𝘮𝘱𝘢𝘳𝘪𝘴𝘰𝘯𝘴 𝘰𝘧 𝘵𝘩𝘦 𝘦𝘧𝘧𝘦𝘤𝘵𝘴 𝘰𝘧 𝘵𝘸𝘰 𝘵𝘺𝘱𝘦𝘴 𝘰𝘧 𝘵𝘪𝘵𝘳𝘢𝘵𝘢𝘣𝘭𝘦 𝘮𝘢𝘯𝘥𝘪𝘣𝘶𝘭𝘢𝘳 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘮𝘦𝘯𝘵 𝘥𝘦𝘷𝘪𝘤𝘦𝘴 𝘰𝘯 𝘳𝘦𝘴𝘱𝘪𝘳𝘢𝘵𝘰𝘳𝘺 𝘱𝘢𝘳𝘢𝘮𝘦𝘵𝘦𝘳𝘴 𝘢𝘯𝘥 𝘶𝘱𝘱𝘦𝘳 𝘢𝘪𝘳𝘸𝘢𝘺 𝘥𝘪𝘮𝘦𝘯𝘴𝘪𝘰𝘯𝘴 𝘪𝘯 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴 𝘸𝘪𝘵𝘩 𝘰𝘣𝘴𝘵𝘳𝘶𝘤𝘵𝘪𝘷𝘦 𝘴𝘭𝘦𝘦𝘱 𝘢𝘱𝘯𝘦𝘢: 𝘢 𝘳𝘢𝘯𝘥𝘰𝘮𝘪𝘻𝘦𝘥 𝘤𝘰𝘯𝘵𝘳𝘰𝘭𝘭𝘦𝘥 𝘵𝘳𝘪𝘢𝘭. 𝘊𝘭𝘪𝘯 𝘖𝘳𝘢𝘭 𝘐𝘯𝘷𝘦𝘴𝘵 27, 2013–2025 (2023). 𝘩𝘵𝘵𝘱𝘴://𝘥𝘰𝘪.𝘰𝘳𝘨/10.1007/𝘴00784-023-04945-𝘻

𝐒𝐨𝐦𝐧𝐨𝐃𝐞𝐧𝐭 𝐀𝐯𝐚𝐧𝐭: 𝐀 𝐧𝐞𝐰 𝐜𝐥𝐚𝐬𝐬 𝐢𝐧 𝐎𝐀𝐓 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬¹ Unlike other studies not finding significant differences between MAD designs²,³ SomnoDent Avant - with passive mouth closing - shows significantly better AHI reduction compared with the traditional wing-based design. Read the research paper: https://lnkd.in/dsEbA8kw #SomnoMed #SomnnoDentAvant #OSAPatients ¹𝘝𝘢𝘯𝘥𝘦𝘳𝘷𝘦𝘬𝘦𝘯 𝘖𝘔, 𝘝𝘢𝘯 𝘋𝘢𝘦𝘭𝘦 𝘔, 𝘝𝘦𝘳𝘣𝘳𝘢𝘦𝘤𝘬𝘦𝘯 𝘑, 𝘉𝘳𝘢𝘦𝘮 𝘔𝘑, 𝘋𝘪𝘦𝘭𝘵𝘫𝘦𝘯𝘴 𝘔. 𝘊𝘰𝘮𝘱𝘢𝘳𝘢𝘵𝘪𝘷𝘦 𝘢𝘯𝘢𝘭𝘺𝘴𝘪𝘴 𝘰𝘧 𝘵𝘸𝘰 𝘤𝘶𝘴𝘵𝘰𝘮-𝘮𝘢𝘥𝘦 𝘮𝘢𝘯𝘥𝘪𝘣𝘶𝘭𝘢𝘳 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘮𝘦𝘯𝘵 𝘥𝘦𝘷𝘪𝘤𝘦𝘴 𝘸𝘪𝘵𝘩 𝘷𝘢𝘳𝘪𝘦𝘥 𝘥𝘦𝘴𝘪𝘨𝘯𝘴 𝘧𝘰𝘳 𝘵𝘳𝘦𝘢𝘵𝘪𝘯𝘨 𝘮𝘰𝘥𝘦𝘳𝘢𝘵𝘦 𝘵𝘰 𝘴𝘦𝘷𝘦𝘳𝘦 𝘰𝘣𝘴𝘵𝘳𝘶𝘤𝘵𝘪𝘷𝘦 𝘴𝘭𝘦𝘦𝘱 𝘢𝘱𝘯𝘦𝘢. 𝘚𝘭𝘦𝘦𝘱 𝘔𝘦𝘥. 2024 𝘔𝘢𝘺;117:95-98. 𝘥𝘰𝘪: 10.1016/𝘫.𝘴𝘭𝘦𝘦𝘱.2024.02.035. 𝘌𝘱𝘶𝘣 2024 𝘔𝘢𝘳 7. 𝘗𝘔𝘐𝘋: 38518588. ᒾ𝘚𝘩𝘪, 𝘟., 𝘓𝘰𝘣𝘣𝘦𝘻𝘰𝘰, 𝘍., 𝘊𝘩𝘦𝘯, 𝘏. 𝘦𝘵 𝘢𝘭. 𝘊𝘰𝘮𝘱𝘢𝘳𝘪𝘴𝘰𝘯𝘴 𝘰𝘧 𝘵𝘩𝘦 𝘦𝘧𝘧𝘦𝘤𝘵𝘴 𝘰𝘧 𝘵𝘸𝘰 𝘵𝘺𝘱𝘦𝘴 𝘰𝘧 𝘵𝘪𝘵𝘳𝘢𝘵𝘢𝘣𝘭𝘦 𝘮𝘢𝘯𝘥𝘪𝘣𝘶𝘭𝘢𝘳 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘮𝘦𝘯𝘵 𝘥𝘦𝘷𝘪𝘤𝘦𝘴 𝘰𝘯 𝘳𝘦𝘴𝘱𝘪𝘳𝘢𝘵𝘰𝘳𝘺 𝘱𝘢𝘳𝘢𝘮𝘦𝘵𝘦𝘳𝘴 𝘢𝘯𝘥 𝘶𝘱𝘱𝘦𝘳 𝘢𝘪𝘳𝘸𝘢𝘺 𝘥𝘪𝘮𝘦𝘯𝘴𝘪𝘰𝘯𝘴 𝘪𝘯 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴 𝘸𝘪𝘵𝘩 𝘰𝘣𝘴𝘵𝘳𝘶𝘤𝘵𝘪𝘷𝘦 𝘴𝘭𝘦𝘦𝘱 𝘢𝘱𝘯𝘦𝘢: 𝘢 𝘳𝘢𝘯𝘥𝘰𝘮𝘪𝘻𝘦𝘥 𝘤𝘰𝘯𝘵𝘳𝘰𝘭𝘭𝘦𝘥 𝘵𝘳𝘪𝘢𝘭. 𝘊𝘭𝘪𝘯 𝘖𝘳𝘢𝘭 𝘐𝘯𝘷𝘦𝘴𝘵 27, 2013–2025 (2023). 𝘩𝘵𝘵𝘱𝘴://𝘥𝘰𝘪.𝘰𝘳𝘨/10.1007/𝘴00784-023-04945-𝘻 ³𝘝𝘦𝘳𝘣𝘶𝘳𝘨 𝘍𝘌, 𝘉𝘰𝘭𝘭𝘦𝘯 𝘒𝘏𝘈, 𝘋𝘰𝘯𝘬𝘦𝘳 𝘏𝘑, 𝘒𝘳𝘢𝘮𝘦𝘳 𝘎𝘑𝘊. 𝘛𝘩𝘦 𝘦𝘧𝘧𝘦𝘤𝘵𝘪𝘷𝘦𝘯𝘦𝘴𝘴 𝘰𝘧 𝘵𝘸𝘰 𝘵𝘺𝘱𝘦𝘴 𝘰𝘧 𝘔𝘈𝘋𝘚 𝘧𝘰𝘳 𝘖𝘚𝘈 𝘵𝘩𝘦𝘳𝘢𝘱𝘺. 𝘊𝘭𝘪𝘯 𝘖𝘳𝘢𝘭 𝘐𝘯𝘷𝘦𝘴𝘵 2018;22:1995–2003.

We’re thrilled to collaborate with the Sleep Research Society on advancing education and evidence on oral appliance therapy. We’re currently taking part in #SLEEP2024, the premier event for clinical and scientific sleep research. Learn more about our mission: https://lnkd.in/eupCkbQh #clinicalresearch #healthinnovation #oralappliancetherapy #sleephealth

Together, we can Treat More OSA Patients, More Effectively. 🤝